➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Colchicine; probenecid - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for colchicine; probenecid and what is the scope of patent protection?

Colchicine; probenecid is the generic ingredient in five branded drugs marketed by Watson Labs, Merck, Ani Pharms Inc, Beecham, Impax Labs, Novast Labs, Sandoz, and Lederle, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for colchicine; probenecid. Three suppliers are listed for this compound.

Summary for colchicine; probenecid
US Patents:0
Drug Master File Entries: 16
Suppliers / Packagers: 3
Clinical Trials: 1
DailyMed Link:colchicine; probenecid at DailyMed
Recent Clinical Trials for colchicine; probenecid

Identify potential brand extensions & 505(b)(2) entrants

Mutual Pharmaceutical Company, Inc.Phase 1

See all colchicine; probenecid clinical trials

Pharmacology for colchicine; probenecid

US Patents and Regulatory Information for colchicine; probenecid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz PROBENECID AND COLCHICINE colchicine; probenecid TABLET;ORAL 086130-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lederle PROBENECID W/ COLCHICINE colchicine; probenecid TABLET;ORAL 086954-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs COL-PROBENECID colchicine; probenecid TABLET;ORAL 084279-001 Approved Prior to Jan 1, 1982 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.